UNCW Center for Marine Science
5600 Marvin K. Moss Lane
Wilmington, North Carolina 28409
Advancing Modern Medicine
Drugs from the Sea
A wellspring of discoveries to treat and cure human diseases is being uncovered in the rapidly growing field of marine biotechnology.
MARBIONC is at the forefront of marine biotechnology research and development on marine natural products and researchers are uncovering their potential to treat or cure a variety of diseases. Several significant medical discoveries are currently in development by the MARBIONC research team.
Extracted from marine algae, Brevenal™ is a unique, patented agent for the symptomatic treatment of patients with cystic fibrosis and Chronic Obstructive Pulmonary Disease (COPD).
This potential new treatment has been shown more effective than existing medical treatments to clear the thick, sticky mucus that builds up in the lungs of patients with pulmonary disorders such as cystic fibrosis and COPD.
Cystic fibrosis is a genetic disorder affecting approximately 30,000 children and adults in the United States and leads to life-threatening lung infections. The World Health Organization estimates that COPD will become the third most common cause of death worldwide by 2020.
Download brochure to learn more about Brevenal™
A series of products recently discovered from marine algae, Escortin™ carriers are capable of “escorting” drugs and medical diagnostics tools directly into cells. This novel new medical escort could revolutionize both medical diagnosis and treatments for cancer, Alzheimer’s and other neurological or central nervous system diseases.
These naturally occurring products have the capability to transform conventional cancer treatment by significantly increasing the absorptivity of otherwise poorly absorbed anti-cancer molecule, potentially improving efficacy while reducing the side-effect profile.
Current medical research and drug discovery is limited by the inability of many diagnostic tools to penetrate a cell’s membrane in order to study the inner-workings of a cell.
MARBIONC Escortin carriers have the potential to greatly enhance medical research by broadening the chemicals and imaging agents that can be transported across the cell membranes, which could result in entirely new research and development studies for human diseases.
Download brochure to learn more about Escortin™ carriers
Race to Stop EHV-1
A new MARBIONC marine discovery currently under development could stop the Equine Herpes Virus (EHV-1) from spreading into an infected horse’s neurological system and prevent the proliferation of equine encephalitis in horses. This anti-viral marine compound may have the ability to stop the new and more virulent strain of EVH-1 that the FDA has identified as an emerging disease due to its increased occurrence in race and competition horses in the United States.